These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 24018911

  • 1. Clinical significance of SPARC gene expression in patients with gastric cancer.
    Sato T, Oshima T, Yamamoto N, Yamada T, Hasegawa S, Yukawa N, Numata K, Kunisaki C, Tanaka K, Shiozawa M, Yoshikawa T, Akaike M, Rino Y, Imada T, Masuda M.
    J Surg Oncol; 2013 Nov; 108(6):364-8. PubMed ID: 24018911
    [Abstract] [Full Text] [Related]

  • 2. Overexpression of SPARC gene in human gastric carcinoma and its clinic-pathologic significance.
    Wang CS, Lin KH, Chen SL, Chan YF, Hsueh S.
    Br J Cancer; 2004 Nov 29; 91(11):1924-30. PubMed ID: 15558074
    [Abstract] [Full Text] [Related]

  • 3. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
    Sato Y, Inokuchi M, Takagi Y, Otsuki S, Fujimori Y, Yanaka Y, Kobayashi K, Higuchi K, Kojima K, Kawano T.
    J Clin Pathol; 2015 Oct 29; 68(10):795-801. PubMed ID: 26043748
    [Abstract] [Full Text] [Related]

  • 4. SPARC is associated with gastric cancer progression and poor survival of patients.
    Zhao ZS, Wang YY, Chu YQ, Ye ZY, Tao HQ.
    Clin Cancer Res; 2010 Jan 01; 16(1):260-8. PubMed ID: 20028745
    [Abstract] [Full Text] [Related]

  • 5. AKR1B10, a good prognostic indicator in gastric cancer.
    Yao HB, Xu Y, Chen LG, Guan TP, Ma YY, He XJ, Xia YJ, Tao HQ, Shao QS.
    Eur J Surg Oncol; 2014 Mar 01; 40(3):318-24. PubMed ID: 24406159
    [Abstract] [Full Text] [Related]

  • 6. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.
    Yang C, Wen Y, Li H, Zhang D, Zhang N, Shi X, Jiang B, Ma X, Yang P, Tang H, Peng Z, Yang Y.
    Oncol Rep; 2012 Jan 01; 27(1):135-42. PubMed ID: 21947329
    [Abstract] [Full Text] [Related]

  • 7. Down-regulated SPARCL1 is associated with clinical significance in human gastric cancer.
    Li P, Qian J, Yu G, Chen Y, Liu K, Li J, Wang J.
    J Surg Oncol; 2012 Jan 01; 105(1):31-7. PubMed ID: 22161898
    [Abstract] [Full Text] [Related]

  • 8. Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: implications for prognosis.
    Porte H, Triboulet JP, Kotelevets L, Carrat F, Prévot S, Nordlinger B, DiGioia Y, Wurtz A, Comoglio P, Gespach C, Chastre E.
    Clin Cancer Res; 1998 Jun 01; 4(6):1375-82. PubMed ID: 9626453
    [Abstract] [Full Text] [Related]

  • 9. Overexpression of matrix metalloproteinase 11 in human gastric carcinoma and its clinicopathologic significance.
    Zhao ZS, Chu YQ, Ye ZY, Wang YY, Tao HQ.
    Hum Pathol; 2010 May 01; 41(5):686-96. PubMed ID: 20060156
    [Abstract] [Full Text] [Related]

  • 10. Downregulation of microRNA-206 is a potent prognostic marker for patients with gastric cancer.
    Yang Q, Zhang C, Huang B, Li H, Zhang R, Huang Y, Wang J.
    Eur J Gastroenterol Hepatol; 2013 Aug 01; 25(8):953-7. PubMed ID: 23751352
    [Abstract] [Full Text] [Related]

  • 11. Significant overexpression of SPARC/osteonectin mRNA in pancreatic cancer compared to cancer of the papilla of Vater.
    Prenzel KL, Warnecke-Eberz U, Xi H, Brabender J, Baldus SE, Bollschweiler E, Gutschow CA, Hölscher AH, Schneider PM.
    Oncol Rep; 2006 May 01; 15(5):1397-401. PubMed ID: 16596217
    [Abstract] [Full Text] [Related]

  • 12. Prognostic significance of osteopontin expression in human gastric carcinoma.
    Higashiyama M, Ito T, Tanaka E, Shimada Y.
    Ann Surg Oncol; 2007 Dec 01; 14(12):3419-27. PubMed ID: 17896150
    [Abstract] [Full Text] [Related]

  • 13. Clinicopathological significance of the gene expression of matrix metalloproteinase-7, insulin-like growth factor-1, insulin-like growth factor-2 and insulin-like growth factor-1 receptor in patients with colorectal cancer: insulin-like growth factor-1 receptor gene expression is a useful predictor of liver metastasis from colorectal cancer.
    Oshima T, Akaike M, Yoshihara K, Shiozawa M, Yamamoto N, Sato T, Yamada R, Fujii S, Rino Y, Kunisaki C, Tanaka K, Masuda M, Imada T.
    Oncol Rep; 2008 Aug 01; 20(2):359-64. PubMed ID: 18636198
    [Abstract] [Full Text] [Related]

  • 14. Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients.
    Nagai MA, Gerhard R, Fregnani JH, Nonogaki S, Rierger RB, Netto MM, Soares FA.
    Breast Cancer Res Treat; 2011 Feb 01; 126(1):1-14. PubMed ID: 20369286
    [Abstract] [Full Text] [Related]

  • 15. Elevated plasma osteopontin associated with gastric cancer development, invasion and survival.
    Wu CY, Wu MS, Chiang EP, Wu CC, Chen YJ, Chen CJ, Chi NH, Chen GH, Lin JT.
    Gut; 2007 Jun 01; 56(6):782-9. PubMed ID: 17148500
    [Abstract] [Full Text] [Related]

  • 16. Overexpression of thrombospondin-1 in stromal myofibroblasts is associated with tumor growth and nodal metastasis in gastric carcinoma.
    Lin XD, Chen SQ, Qi YL, Zhu JW, Tang Y, Lin JY.
    J Surg Oncol; 2012 Jul 01; 106(1):94-100. PubMed ID: 22231149
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Analysis of the gene expression of SPARC and its prognostic value for bladder cancer.
    Yamanaka M, Kanda K, Li NC, Fukumori T, Oka N, Kanayama HO, Kagawa S.
    J Urol; 2001 Dec 01; 166(6):2495-9. PubMed ID: 11696817
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.